No evidence that major mtDNA European haplogroups confer risk to schizophrenia

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 159 B, Issue 4, 2012, Pages 414-421

  Mosquera Miguel, Ana ^a   Torrell, Helena ^b   Abasolo, Nerea ^b   Arrojo, Manuel ^c   Paz, Eduardo ^c   Ramos Ríos, Ramón ^c   Agra, Santiago ^c   Páramo, Mario ^c   Brenlla, Julio ^c   Martínez, Silvia ^c   Vilella, Elisabet ^b   Valero, Joaquín ^b   Gutiérrez Zotes, Alfonso ^b   Martorell, Lourdes ^b   Costas, Javier ^a   Salas, Antonio ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b IISPV   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Association studies; False positive; Mitochondrial DNA; Population stratification; SNPs

Indexed keywords

MITOCHONDRIAL DNA;

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; EUROPE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYLOGENY; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; DNA, MITOCHONDRIAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SCHIZOPHRENIA;

EID: 84860605689     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32044     Document Type: Article

References (53)

1. Abramson JH. 2004. WINPEPI (PEPI-for-Windows): Computer programs for epidemiologists. Epidemiol Perspect Innov 1(1): 6.
2. Achilli A, Rengo C, Magri C, Battaglia V, Olivieri A, Scozzari R, Cruciani F, Zeviani M, Briem E, Carelli V, et al. 2004. The molecular dissection of mtDNA haplogroup H confirms that the Franco-Cantabrian glacial refuge was a major source for the European gene pool. Am J Hum Genet 75(5): 910-918.
3. Altar CA, Jurata LW, Charles V, Lemire A, Liu P, Bukhman Y, Young TA, Bullard J, Yokoe H, Webster MJ, et al. 2005. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry 58(2): 85-96.
4. Álvarez-Iglesias V, Jaime JC, Carracedo Á, Salas A. 2007. Coding region mitochondrial DNA SNPs: Targeting East Asian and Native American haplogroups. Forensic Sci Int Genet 1: 44-55.
5. Álvarez-Iglesias V, Barros F, Carracedo Á, Salas A. 2008. Minisequencing mitochondrial DNA pathogenic mutations. BMC Med Genet 9: 26.
6. Álvarez-Iglesias V, Mosquera-Miguel A, Cerezo M, Quintáns B, Zarrabeitia MT, Cuscó I, Lareu MV, García O, Pérez-Jurado L, Carracedo Á, et al. 2009. New population and phylogenetic features of the internal variation within mitochondrial DNA macro-haplogroup R0. PLoS One 4(4): e5112.
7. Amar S, Shamir A, Ovadia O, Blanaru M, Reshef A, Kremer I, Rietschel M, Schulze TG, Maier W, Belmaker RH, et al. 2007. Mitochondrial DNA HV lineage increases the susceptibility to schizophrenia among Israeli Arabs. Schizophr Res 94(1-3): 354-358.
8. Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, Howell N. 1999. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 23: 147.
9. Bandelt H-J, Quintana-Murci L, Salas A, Macaulay V. 2002. The fingerprint of phantom mutations in mitochondrial DNA data. Am J Hum Genet 71(5): 1150-1160.
10. Bandelt H-J, Salas A, Lutz-Bonengel S. 2004a. Artificial recombination in forensic mtDNA population databases. Int J Legal Med 118(5): 267-273.
11. Bandelt H-J, Salas A, Bravi C. 2004b. Problems in FBI mtDNA database. Science 305(5689): 1402-1404.
12. Bandelt H-J, Yao Y-G, Kivisild T. 2005. Mitochondrial genes and schizophrenia. Schizophr Res 72(2-3): 267-269.
13. Bandelt H-J, Olivieri A, Bravi CM, Yao Y-G, Torroni A, Salas A. 2007. 'Distorted' mitochondrial DNA sequences in schizophrenic patients. Eur J Hum Genet 15: 400-404.
14. Ben-Shachar D, Laifenfeld D. 2004. Mitochondria, synaptic plasticity, and schizophrenia. Int Rev Neurobiol 59: 273-296.
15. Bertolin C, Magri C, Barlati S, Vettori A, Perini GI, Peruzzi P, Mostacciuolo ML, Vazza G. 2011. Analysis of complete mitochondrial genomes of patients with schizophrenia and bipolar disorder. J Hum Genet 56(12): 869-872.
16. Carrera N, Arrojo M, Sanjuán J, Ramos-Ríos R, Paz E, Suárez-Rama JJ, Páramo M, Agra S, Brenlla J, Martínez S, et al. 2012. Association study of non-synonymous single nucleotide polymorphisms in schizophrenia. Biol Psychiatry 71(2): 169-177.
17. Cerezo M, Černý V, Carracedo Á, Salas A. 2009. Applications of MALDI-TOF MS to large-scale human mtDNA population-based studies. Electrophoresis 30(21): 3665-3673.
18. Clay HB, Sillivan S, Konradi C. 2011. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci 29(3): 311-324.
19. Do KQ, Trabesinger AH, Kirsten-Kruger M, Lauer CJ, Dydak U, Hell D, Holsboer F, Boesiger P, Cuenod M. 2000. Schizophrenia: Glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. Eur J Neurosci 12(10): 3721-3728.
20. Do KQ, Cabungcal JH, Frank A, Steullet P, Cuenod M. 2009. Redox dysregulation, neurodevelopment, and schizophrenia. Curr Opin Neurobiol 19(2): 220-230.
21. Doi N, Hoshi Y, Itokawa M, Usui C, Yoshikawa T, Tachikawa H. 2009. Persistence criteria for susceptibility genes for schizophrenia: A discussion from an evolutionary viewpoint. PLoS One 4(11): e7799.
22. Fattal O, Budur K, Vaughan AJ, Franco K. 2006. Review of the literature on major mental disorders in adult patients with mitochondrial diseases. Psychosomatics 47(1): 1-7.
23. Gauderman WJ. 2002. Sample size requirements for matched case-control studies of gene-environment interaction. Stat Med 21(1): 35-50.
24. Giles RE, Blanc H, Cann HM, Wallace DC. 1980. Maternal inheritance of human mitochondrial DNA. Proc Natl Acad Sci USA 77(11): 6715-6719.
25. Goldstein JM, Faraone SV, Chen WJ, Tsuang MT. 1992. Gender and the familial risk for schizophrenia. Disentangling confounding factors. Schizophr Res 7(2): 135-140.
26. Gysin R, Kraftsik R, Sandell J, Bovet P, Chappuis C, Conus P, Deppen P, Preisig M, Ruiz V, Steullet P, et al. 2007. Impaired glutathione synthesis in schizophrenia: Convergent genetic and functional evidence. Proc Natl Acad Sci USA 104(42): 16621-16626.
27. Loogväli E-L, Roostalu U, Malyarchuk BA, Derenko MV, Kivisild T, Metspalu E, Tambets K, Reidla M, Tolk H-V, Parik J, et al. 2004. Disuniting uniformity: A pied cladistic canvas of mtDNA haplogroup H in Eurasia. Mol Biol Evol 21(11): 2012-2021.
28. Magri C, Gardella R, Barlati SD, Valsecchi P, Sacchetti E, Barlati S. 2007. Mitochondrial DNA haplogroups and age at onset of schizophrenia. Am J Med Genet Part B 144B(4): 496-501.
29. Martorell L, Segues T, Folch G, Valero J, Joven J, Labad A, Vilella E. 2006. New variants in the mitochondrial genomes of schizophrenic patients. Eur J Hum Genet 14(5): 520-528.
30. Mosquera-Miguel A, Álvarez-Iglesias V, Vega A, Milne R, Cabrera de León A, Benitez J, Carracedo Á, Salas A. 2008. Is mitochondrial DNA variation associated with sporadic breast cancer risk? Cancer Res 68(2): 623-625.
31. O'Donovan MC, Williams NM, Owen MJ. 2003. Recent advances in the genetics of schizophrenia. Hum Mol Genet 12(Spec No 2): R125-R133.
32. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL, Wayland M, Freeman T, Dudbridge F, Lilley KS, et al. 2004. Mitochondrial dysfunction in schizophrenia: Evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 9(7): 684-697, 643.
33. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P. 2009. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460(7256): 748-752.
34. Quintáns B, Álvarez-Iglesias V, Salas A, Phillips C, Lareu MV, Carracedo Á. 2004. Typing of mitochondrial DNA coding region SNPs of forensic and anthropological interest using SNaPshot minisequencing. Forensic Sci Int 140(2-3): 251-257.
35. Regenold WT, Phatak P, Marano CM, Sassan A, Conley RR, Kling MA. 2009. Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: Implications for the mitochondrial dysfunction hypothesis. Biol Psychiatry 65(6): 489-494.
36. Roig B, Virgos C, Franco N, Martorell L, Valero J, Costas J, Carracedo Á, Labad A, Vilella E. 2007. The discoidin domain receptor 1 as a novel susceptibility gene for schizophrenia. Mol Psychiatry 12(9): 833-841.
37. Rollins B, Martin MV, Sequeira PA, Moon EA, Morgan LZ, Watson SJ, Schatzberg A, Akil H, Myers RM, Jones EG, et al. 2009. Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder. PLoS One 4(3): e4913.
38. Saha S, Chant D, Welham J, McGrath J. 2005. A systematic review of the prevalence of schizophrenia. PLoS Med 2(5): e141.
39. Salas A, Carracedo Á, Macaulay V, Richards M, Bandelt H-J. 2005a. A practical guide to mitochondrial DNA error prevention in clinical, forensic, and population genetics. Biochem Biophys Res Commun 335(3): 891-899.
40. Salas A, Yao Y-G, Macaulay V, Vega A, Carracedo A, Bandelt H-J. 2005b. A critical reassessment of the role of mitochondria in tumorigenesis. PLoS Med 2(11): e296.
41. Salas A, Fachal L, Marcos-Alonso S, Vega A, Martinón-Torres F, ESIGEM G. 2009. Investigating the role of mitochondrial haplogroups in genetic predisposition to meningococcal disease. PLoS One 4(12): e8347.
42. Shao L, Martin MV, Watson SJ, Schatzberg A, Akil H, Myers RM, Jones EG, Bunney WE, Vawter MP. 2008. Mitochondrial involvement in psychiatric disorders. Ann Med 40(4): 281-295.
43. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, Werge T, Pietilainen OP, Mors O, Mortensen PB, et al. 2009. Common variants conferring risk of schizophrenia. Nature 460(7256): 744-747.
44. Steinberg S, de Jong S, Andreassen OA, Werge T, Borglum AD, Mors O, Mortensen PB, Gustafsson O, Costas J, Pietilainen OP, et al. 2011. Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet 15(20): 4076-4081.
45. Sullivan PF. 2005. The genetics of schizophrenia. PLoS Med 2(7): e212.
46. Tomita H, Vawter MP, Walsh DM, Evans SJ, Choudary PV, Li J, Overman KM, Atz ME, Myers RM, Jones EG, et al. 2004. Effect of agonal and postmortem factors on gene expression profile: Quality control in microarray analyses of postmortem human brain. Biol Psychiatry 55(4): 346-352.
47. Torroni A, Bandelt H-J, Macaulay V, Richards M, Cruciani F, Rengo C, Martínez-Cabrera V, Villems R, Kivisild T, Metspalu E, et al. 2001. A signal, from human mtDNA, of postglacial recolonization in Europe. Am J Hum Genet 69(4): 844-852.
48. Tosic M, Ott J, Barral S, Bovet P, Deppen P, Gheorghita F, Matthey ML, Parnas J, Preisig M, Saraga M, et al. 2006. Schizophrenia and oxidative stress: Glutamate cysteine ligase modifier as a susceptibility gene. Am J Hum Genet 79(3): 586-592.
49. Ueno H, Nishigaki Y, Kong Q-P, Fuku N, Kojima S, Iwata N, Ozaki N, Tanaka M. 2009. Analysis of mitochondrial DNA variants in Japanese patients with schizophrenia. Mitochondrion 9(6): 385-393.
50. Uranova N, Orlovskaya D, Vikhreva O, Zimina I, Kolomeets N, Vostrikov V, Rachmanova V. 2001. Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull 55(5): 597-610.
51. Vawter MP, Tomita H, Meng F, Bolstad B, Li J, Evans S, Choudary P, Atz M, Shao L, Neal C, et al. 2006. Mitochondrial-related gene expression changes are sensitive to agonal-pH state: Implications for brain disorders. Mol Psychiatry 11(7): 615, 663-679.
52. Verge B, Alonso Y, Valero J, Miralles C, Vilella E, Martorell L. 2011. Mitochondrial DNA (mtDNA) and schizophrenia. Eur Psychiatry 26(1): 45-456.
53. Wolyniec PS, Pulver AE, McGrath JA, Tam D. 1992. Schizophrenia: Gender and familial risk. J Psychiatr Res 26(1): 17-27.